Skip to main content
Clinical Trials/NCT03434678
NCT03434678
Completed
Phase 3

Randomized Controlled Trial of Epidural-General Anesthesia Versus General Anesthesia for Open Pancreaticoduodenectomy: Influence on Complications and Overall Two Year Survival

Memorial Sloan Kettering Cancer Center3 sites in 1 country133 target enrollmentJanuary 30, 2018

Overview

Phase
Phase 3
Intervention
Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
Conditions
Pancreatic Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
133
Locations
3
Primary Endpoint
Number of Incidences of Grade 3 or Greater Complications
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

The purpose of this study is to see if there is a difference in complications in patients who have an epidural started earlier (during their surgery) and used as part of the anesthetic in addition to using it for post operative pain compared with patients who receive an epidural later in the surgery to be used only for post operative pain.

Registry
clinicaltrials.gov
Start Date
January 30, 2018
End Date
July 10, 2024
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients ≥ 18 years of age who can provide informed consent
  • Scheduled for pancreaticoduodenectomy

Exclusion Criteria

  • Pregnancy
  • History of documented anaphylaxis or contraindication to any of the study medications
  • Significant cognitive impairment or documented psychologic impairment
  • Contraindication to epidural per Pain Service guidelines
  • Use of a sustained release opioid medication such as long-acting morphine, fentanyl patches, methadone, and buprenorphine within the last 3 months
  • Post randomization exclusion will occur if the patient is found to have unresectable disease at laparotomy and therefore will not have the potential for the same postoperative complications.

Arms & Interventions

Epidural-General Anesthesia

Intervention: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml

Epidural-General Anesthesia

Intervention: Open Pancreaticoduodenectomy

General Anesthesia

Intervention: Propofol+ Rocuronium+ Fentanyl + Inhalational

General Anesthesia

Intervention: Open Pancreaticoduodenectomy

Outcomes

Primary Outcomes

Number of Incidences of Grade 3 or Greater Complications

Time Frame: 90 days post operatively

Complications will be graded in severity according to the MSKCC Graded Post Operative Complications Criteria based on the modified Dindo, Clavien classification of surgical complications, a grading system commonly used for this procedure.3,4 This classification grades complications from 1-5, with Grade 1 complications requiring bedside intervention. Grade 2 requires moderate interventions, such as intravenous medications. Grade 3 requires either a surgical, endoscopic or interventional radiology procedure for treatment. Grade 4 results in chronic deficit or disability. Grade 5 complications result in death.

Study Sites (3)

Loading locations...

Similar Trials